“…Considering that inhibition of heterotypic Sam-Sam interactions involving EphA2 could be a promising route in cancer therapy, during the last few years, we centered our research activities on the design of peptides able to hamper these interactions. To achieve our goal and obtain such peptides we implemented a variety of approaches: (1) we set-up protein dissection strategies involving all Sam domains under study (i.e., EphA2-Sam, Ship2-Sam and Odin-Sam1) [ 187 , 188 , 189 , 190 ], (2) we designed helical peptides, both linear and stapled, to mimic native-like structural motives in Sam domains [ 191 , 192 ], (3) we implemented structure-based computational approaches to generate virtual peptide libraries to be screened in silico against target Sam domains [ 92 , 193 ]. All designed peptides were evaluated through multidisciplinary studies involving diverse computational and experimental techniques such as NMR and CD (Circular Dichroism) for conformational studies, molecular modelling (docking), NMR, ITC, SPR and MST (Microscale Thermophoresis) for binding analyses, and in vitro cell-based assays for evaluation of biological activities.…”